A robotic system, developed by Shanghai-based tech company MicroPort, has helped complete a Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) at a hospital in the metropolis, China’s first such surgery by a domestically made device. (Photo/China Youth Daily)

A robotic system, developed by Shanghai-based tech company MicroPort, has helped complete a Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) at a hospital in the metropolis, China’s first such surgery by a domestically made device.

The system, named Tumai, allows the surgeon to move robotic arms and complete the surgery with a better range of motion than that of the human hand, cutting the operation time and creating less impact on nerves and blood vessels.

In the United States, 85 percent of patients receive treatment through the use of RALRP surgery.

Sun Yinghao, an academician at the Chinese Academy of Engineering, said till now China’s RALRP surgeries were completed using imported systems, meaning a higher cost and limited choice, but Toumai is set to change this situation due its technical strengths.

The robot also applies homegrown technologies and makes it easier for surgeons to operate. A technical innovation, the robot will hit the market after review by China Drug Administration.